QURE Latest Headlines

FDA Feedback Challenges QURE’s Huntington’s Therapy Timeline—Regulatory Path Uncertain After Phase I/II Data

Market Chameleon (Thu, 4-Dec 9:54 AM)

FDA Feedback Raises Bar for uniQure’s AMT-130 Huntington’s Therapy—Company to Seek Rapid Follow-up Meeting

Market Chameleon (Thu, 4-Dec 7:28 AM)

uniQure’s AMT-130 Hits Major Huntington’s Milestone as Regulatory Uncertainty Emerges

Market Chameleon (Mon, 10-Nov 7:47 AM)

uniQure Schedules Q3 2025 Financial Results—All Eyes on Upcoming Gene Therapy Pipeline Updates

Market Chameleon (Thu, 6-Nov 8:05 AM)

FDA Alters Path for uniQure’s AMT-130 in Huntington’s Disease, Raising Uncertainty Around Accelerated Approval

Market Chameleon (Mon, 3-Nov 7:35 AM)